M Cimarra

Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

Erkka Valovirta, Thomas Houmann Petersen, Teresa Piotrowska et al. · Journal of Allergy and Clinical Immunology · 2017 · 330 citations · Full text

<i>A</i> double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy

Isbet Marín Dolz, C. Martínez‐Cócera, J. M. Bartolomé et al. · Allergy · 1996 · 106 citations · Full text

A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy

Isbet Marín Dolz, C. Martínez‐Cócera, J. M. Bartolomé et al. · Allergy · 1996 · 52 citations

Allergy Medicine, Immunology, Oral Immunotherapy +9

Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity–standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study

Pilar Serrano, José-Luis Justicia, Cesárea Sánchez et al. · Annals of Allergy Asthma & Immunology · 2009 · 31 citations

Systemic Tolerability, Drug Hypersensitivity, Allergy +10

Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract.

C. Martínez‐Cócera, J. Sastre, M Cimarra et al. · PubMed · 2010 · 22 citations